Search
Tisolagiline
go.drugbank.com/drugs/DB21655ExperimentalTisolagiline has a monoisotopic molecular weight of 322.13 Da.
Mosperafenib
go.drugbank.com/drugs/DB21673ExperimentalMosperafenib has a monoisotopic molecular weight of 461.1 Da.
Rotigotine
go.drugbank.com/drugs/DB05271ApprovedInvestigationalHowever, all Neupro patches in the United States and some of Europe were recalled in 2008 due to delivery mechanism issues. Rotigotine has been authorized as a treatment for RLS since August 2008.
Garadacimab
go.drugbank.com/drugs/DB15629Approved[L53283,A273998] Garadacimab received its first approval in Australia and the UK in January 2025, and has since been approved in a number of other jurisdictions, including the EU and Japan.
Posizolid
go.drugbank.com/drugs/DB04850InvestigationalIn July 2002, after completion of phase I trials in December 2001, AstraZeneca announced that they were no longer pursuing the development of Posizolid, presumably due to negative trial results (though
Hu-rhEGF-rP64k/Mont
go.drugbank.com/drugs/DB15781InvestigationalHu-rhEGF-rP64k/Mont is a therapeutic vaccine composed by an antigen (recombinant human EGF (rhEGF) chemically conjugated to recombinant P64K (rP64K)) and an adjuvant (Montanide ISA51VG) being investigated
Synonyms: Hu-rhEGF-rP64k/MontTocofibrate
go.drugbank.com/drugs/DB19752ExperimentalTocofibrate has a monoisotopic molecular weight of 626.41 Da.
Nicofibrate
go.drugbank.com/drugs/DB19916ExperimentalNicofibrate has a monoisotopic molecular weight of 305.08 Da.
Dulofibrate
go.drugbank.com/drugs/DB20032ExperimentalDulofibrate has a monoisotopic molecular weight of 324.03 Da.
Pirifibrate
go.drugbank.com/drugs/DB20620ExperimentalPirifibrate has a monoisotopic molecular weight of 335.09 Da.